Clinical trial Recruiting at 1 site Observational Ages 18 to 60 Women only

Using AI to detect fetal brain anomalies during second trimester ultrasounds

Official title: Development of an Artificial Intelligence Algorithm to Recognize Abnormal Findings at Routine Fetal Brain Ultrasound. AIRFRAME (Artificial Intelligence for Recognition of Fetal bRain AnoMaliEs)

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06675266 · Data updated 2026-11-12

This study is testing a new AI software to see if it can help doctors find brain problems in babies during second trimester ultrasounds.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexWomen only
Enrollment10000 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome)
StatusRecruiting
StartedApril 30, 2023
Main results expectedDecember 30, 2024
Study endsDecember 30, 2026
Registry record updatedNovember 5, 2024
Trial IDNCT06675266 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women with singleton pregnancies who are undergoing ultrasound examinations between 19 and 22 weeks of gestation.

Probably not a fit

Patients who do not have a clear visualization of the fetal brain structures during the ultrasound or who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop and validate an AI-based software designed to recognize fetal brain structures and identify abnormalities during second trimester ultrasound scans. The study will be conducted in two phases: a retrospective phase to train the AI algorithm using previously acquired ultrasound images, followed by a prospective phase to test the algorithm in real clinical settings. The goal is to enhance the accuracy and efficiency of fetal brain anomaly detection, ultimately improving prenatal care and management.

Why it matters

Potential benefit: If successful, this AI technology could significantly improve the early detection of fetal brain anomalies, leading to better prenatal counseling and management.

How similar studies have gone: While the application of AI in medical diagnostics is gaining traction, this specific approach to fetal brain anomaly detection is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with singleton pregnancies undergoing ultrasound examination between 19+0 - 22+6 weeks of gestation

Exclusion Criteria:

* Women who did not have the second trimester screening scan at the settled gestational age.
* Women in which a good visualization of the transventricular, transthalamic and transcerebellar plane of the fetal head was not technically possible.
* Women who are not able to give the informed consent.

Where it's running

  • Fondazione Policlinico Universitario Agostino Gemelli
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.